Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keerti Jain

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|January 19, 2022
Theranostic Applications of NanomaterialsKeerti Jain, Jian Zhong
Drug Discovery Today|September 19, 2017
Molecular targets and pathways for the treatment of visceral leishmaniasisVineet Jain, Keerti Jain
Journal of Immunological Methods|April 11, 2015
Vaccines for visceral leishmaniasis: A reviewKeerti Jain, N K Jain
Drug Discovery Today|August 27, 2013
Novel therapeutic strategies for treatment of visceral leishmaniasisKeerti Jain, Narendra K Jain
AAPS Pharmscitech|November 9, 2023
One Platform Comparison of Polymeric and Lipidic Nanoparticles for the Delivery of Amphotericin BNandha Joyson, Anchal Pathak, Keerti Jain
Nanomedicine (London, England)|October 26, 2025
Development and characterization of multifunctional dendrimeric nanoconjugates for delivery of rutin: <i>in vitro</i> characterization for potential neuroprotective applicationAbhishek Sonwani, Anchal Pathak, Keerti Jain
Food Research International (Ottawa, Ont.)|November 27, 2024
Effect of Tween 80 and Pluronic 127 on the stabilization of zein nanocarriers for the delivery of piperineK Sivasankar, Anchal Pathak, Keerti Jain
Nanomedicine (London, England)|February 2, 2024
Novel ligand decorated theranostic zein nanoparticles coloaded with paclitaxel and carbon quantum dots: formulation and optimizationParth Patel, Anchal Pathak, Keerti Jain
Expert Opinion on Drug Delivery|January 20, 2024
Conjugates of amphotericin B to resolve challenges associated with its deliveryVineet Kumar Jain, Keerti Jain, Harvinder Popli
Current Pharmaceutical Design|February 16, 2019
3D Printing in Personalized Drug DeliveryAfsana, Vineet Jain, Nafis Haider, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|January 19, 2022
Theranostic Applications of NanomaterialsKeerti Jain, Jian Zhong
Drug Discovery Today|September 19, 2017
Molecular targets and pathways for the treatment of visceral leishmaniasisVineet Jain, Keerti Jain
Journal of Immunological Methods|April 11, 2015
Vaccines for visceral leishmaniasis: A reviewKeerti Jain, N K Jain
Drug Discovery Today|August 27, 2013
Novel therapeutic strategies for treatment of visceral leishmaniasisKeerti Jain, Narendra K Jain
AAPS Pharmscitech|November 9, 2023
One Platform Comparison of Polymeric and Lipidic Nanoparticles for the Delivery of Amphotericin BNandha Joyson, Anchal Pathak, Keerti Jain
Nanomedicine (London, England)|October 26, 2025
Development and characterization of multifunctional dendrimeric nanoconjugates for delivery of rutin: <i>in vitro</i> characterization for potential neuroprotective applicationAbhishek Sonwani, Anchal Pathak, Keerti Jain
Food Research International (Ottawa, Ont.)|November 27, 2024
Effect of Tween 80 and Pluronic 127 on the stabilization of zein nanocarriers for the delivery of piperineK Sivasankar, Anchal Pathak, Keerti Jain
Nanomedicine (London, England)|February 2, 2024
Novel ligand decorated theranostic zein nanoparticles coloaded with paclitaxel and carbon quantum dots: formulation and optimizationParth Patel, Anchal Pathak, Keerti Jain
Expert Opinion on Drug Delivery|January 20, 2024
Conjugates of amphotericin B to resolve challenges associated with its deliveryVineet Kumar Jain, Keerti Jain, Harvinder Popli
Current Pharmaceutical Design|February 16, 2019
3D Printing in Personalized Drug DeliveryAfsana, Vineet Jain, Nafis Haider, et al.
Pageof 5